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001: Genetic diversity in Indian populations
and its implications in health and disease
Lalji Singh
Centre for Cellular and Molecular Biology (CCMB), Hyderabad,
India
India represents one of the largest source of human biodiversity,
consisting of 4,635 culturally and anthropologically well-defined
populations with little or no gene flow between them. Hence, study on
Indian populations, who are known for their cultural and genetic
diversity, not only provides insight into their complex origin, history
and relatedness, but also helps in understanding molecular pathology
of genetic diseases. Therefore, our interest has been to study both
population history and molecular mechanism of diseases among
Indian populations. Our study on nearly \10,000 individuals
belonging to more than 200 ethnic populations of India, using Y
chromosome and mtDNA markers, revealed that the tribal popula-
tions of Andaman Islands are probably the descendants of the first
modern humans migrated out of Africa about 65,000–70,000 years
ago. Our very recent study using 1 million autosomal SNPs further
confirms that the Andamanese are very unique, and possibly con-
tributed to the origin of Australian aboriginal and Southeast Asian
populations. Further, we have also found that several novel mtDNA
haplogroups have originated within India and some of them might be
the source of mtDNA and Y chromosome lineages found in Southeast
Asia. As each Indian population is unique in their genetic composi-
tion, etiologies of genetic diseases are often different from other
global populations. For example, in Indian population, we identified
an ancient deletion of 25 bp in the cardiac myosin-binding protein-C
gene (MYBPC3) that is associated with heritable cardiomyopathies as
well as with an increased risk of heart failure. Its prevalence was
found to be high (*4%) in the general population from the Indian
subcontinent. However, this mutation is completely absent among the
people from the rest of the world. Mutations in SRY and SOX9 were
found to be the main cause for the sex-reversals, but when we ana-
lysed several familial cases of sex-reversals, we found a novel region
on Xp11 involved in the etiology of the disease. Similarly, we have
observed novel variations in DAZ, SPINK1 and CYP1A1 genes in
individuals associated with infertility, fibrocalculous pancreatic dia-
betes, and recurrent early pregnancy loss, respectively. These studies
suggest that the Indian populations are unique in their genetic origin
as well as in the mutations underlying in the susceptibility to disease.
Therefore, what is true for other global populations, in terms of their
genetic basis for disease susceptibility, may not be true for Indian
populations.
002: Mapping human genetic history in Asia
Mark Seielstad
The Pan-Asian SNP Initiative, Genome Institute of Singapore,
60 Biopolis St., Singapore
Asia, as the largest and most populous continent, harbors significant
cultural and linguistic diversity, but the geographic structure of genetic
variation across the continent remains enigmatic. Here, we report a
large-scale survey of autosomal variation from a broad geographic
sample of Asian populations: more than 50,000 single nucleotide
polymorphisms (SNPs) typed in 1,808 DNA samples representing 73
Asian populations. Our results show considerable relatedness amongst
all Asian populations and suggest a predominantly south-to-north
migration of East Asian populations. Analyses suggest a common
ancestral origin for all East and Southeast Asian populations studied,
implying that the majority of the gene pool in Asia was derived from a
single initial entry of modern humans into the continent.
003: The first sequenced Asian genome
Jun Wang
Beijing Institute of Genomics, Chinese Academy of Sciences,
Beijing 101300, China
We have finished a Han Chinese male individual genome with 21X
single-ended and 13X pair-ended reads generated by Illumina Gen-
ome Analyzer. The sequence has 99.97% coverage of NCBI v36.1
reference, over 90% of which are unique. About 3M SNPs and
417,016 novel ones were discovered in highly confidence, meeting
99.9% coincidence with Illumina Human 1M Genotyping result.
215,982 indels as well as 1,602 structural variations were also found.
In addition, comparing the sequence with three previous European
genomes had resulted in a better understanding of human evolution.
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The project is the first huge genome completed by ‘‘Now-Gen’’
sequencing technology. It demonstrated the powerful capability of the
new generation sequencer on whole genome resequencing and shed
light on a promising future era of personal genomics and personalized
health care.
004: The Indian genome Variation project: Clues
and cues for pharmaco-genomics and disease
association studies
Mitali Mukerji
The Indian Genome Variation Consortium, Institute of Genomics
and Integrative Biology, CSIR, Mall Road, Delhi, India
The Indian Genome Variation (IGV) project has been evolved to
enable genotype-phenotype correlations in complex disorders and
pharmacogenomic studies in diverse populations of India. Since
India houses nearly one-sixth of the world’s population and is a
global melting pot of human diversity, the first major challenge was
to identify a representative set of populations which captures the
genetic spectrum of India. This was carried out through a grid
sampling approach wherein genetic relatedness amongst 55 popula-
tions encompassing four major linguistic lineages i.e. Indo-
European, Tibeto-Burman, Austro-siatic and Dravidian of contrast-
ing ethnicity from different geographical zones was analysed using a
subset of 75 genes representing nearly all the chromosomes. The
analysis revealed the existence of a population sub-structure. These
55 populations however, could be classified into four genetically
distinct and near homogeneous clusters and one bridged population
group. Variation data on over 1,000 disease and drug candidate loci
from diverse functional categories including validated functional
polymorphisms with reported associations in different populations is
now available from 26 representative populations of the clusters in
the Indian Genome Variation database (http://www.igvdb.res.in/).
Additionally it houses genotype data on *58K neutral markers from
Affy 50K array. Analysis of this data has (1) revealed clusters of
populations which are related to different HapMap as well as Pan-
Asian populations. Indian populations form a continuum of genetic
spectrum bridging CEU and JPT/CHB, the two most distinct HAP-
MAP populations. (2) It has also enabled estimation of the extent of
genetic heterogeneity within Indian populations and thus provided
pointers for cohort pooling and validation studies (3) hinted at genes/
variations which are preferentially targeted by natural/balancing
selection and would thus be important disease/drug response candi-
dates. (4) predicted at risk/protected populations for various diseases.
This would be enormously useful for epidemiological and phar-
macogenomic studies (5) enabled identification of common CNV
regions and their frequency in various Indian populations (6) pro-
vided guidelines for more effective LD based mutation mapping,
founder identification and use of IGVdb data as controls for asso-
ciation studies.
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